Suchergebnisse - "Mason, Kayleigh J"

PubPharm (7)

1

HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis

enthalten in: The Journal of allergy and clinical immunology | 2019

von Dand, N. | Duckworth, M. | Baudry, D. | +37

2

Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR

enthalten in: JAMA dermatology | 2018

von Mason, K. | Barker, J. | Smith, C. | +8

ErratumIn: JAMA Dermatol. 2018 Jul 1;154(7):852. - PMID 29998309

3

Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis : Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

enthalten in: The Journal of investigative dermatology | 2018

von Iskandar, I. | Warren, R. | Lunt, M. | +8

CommentIn: J Invest Dermatol. 2018 Apr;138(4):726-728. - PMID 29579453

4

Psychosocial factors partially mediate the relationship between mechanical hyperalgesia and self-reported pain

enthalten in: Scandinavian journal of pain | 2018

von Mason, K. | O’Neill, T. | Lunt, M. | +2

5

Psychosocial factors partially mediate the relationship between mechanical hyperalgesia and self-reported pain

enthalten in: Scandinavian journal of pain | 2018

von Mason, K. | O'Neill, T. | Lunt, M. | +2

6

Psychosocial factors partially mediate the relationship between mechanical hyperalgesia and self-reported pain

enthalten in: Scandinavian journal of pain | 2018

von Mason, K. | O’Neill, T. | Lunt, M. | +2

7

Psychosocial factors partially mediate the relationship between mechanical hyperalgesia and self-reported pain

enthalten in: Scandinavian journal of pain | 2018

von Mason, K. | O’Neill, T. | Lunt, M. | +2

1
[1]